Literature DB >> 29056505

Ly6Chi monocytes are required for mesenchymal stem/stromal cell-induced immune tolerance in mice with experimental autoimmune uveitis.

Jung Hwa Ko1, Hyun Ju Lee1, Hyun Jeong Jeong1, Joo Youn Oh2.   

Abstract

The cells of the innate immune system, in addition to their capacity to elicit immunity, play a substantial role in immune tolerance induction. Our group has recently shown that a distinct subset of MHC IIhiB220hiCD11bmid suppressive macrophages is increased in the lung by intravenous (IV) administration of mesenchymal stem/stromal cells (MSC) and induces immune tolerance. Herein, we demonstrate that circulating CD11bhiLy6Chi monocytes are precursors to MHC IIhiB220hiCD11bmid macrophages in the lung and required for MSC-induced tolerance in a mouse model of experimental autoimmune uveitis (EAU). Analysis revealed that IV MSC induced an increase in IL-10-expressing MHC IIhiB220hiCD11bmid macrophages in the lung with a concomitant decrease in CD11bhiLy6Chi monocytes. Selective depletion of circulating CD11bhiLy6Chi cells abrogated the effects of MSC in the induction of IL-10hiMHC IIhiB220hiCD11bmid macrophages and immune tolerance in EAU mice. Similarly, an increase in CD4+CD25+Foxp3+ Tregs by MSCs was also reversed by CD11bhiLy6Chi cell depletion. These results suggest that CD11bhiLy6Chi monocytes are critical for MSC-induced immune tolerance.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Experimental autoimmune uveitis; Immune tolerance; Ly6C(hi) monocyte; Mesenchymal stem/stromal cell; Regulatory T cell; Suppressive macrophage

Mesh:

Substances:

Year:  2017        PMID: 29056505     DOI: 10.1016/j.bbrc.2017.10.097

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Mesenchymal stromal cells induce distinct myeloid-derived suppressor cells in inflammation.

Authors:  Hyun Ju Lee; Jung Hwa Ko; Hyeon Ji Kim; Hyun Jeong Jeong; Joo Youn Oh
Journal:  JCI Insight       Date:  2020-06-18

2.  Genetic landscape and autoimmunity of monocytes in developing Vogt-Koyanagi-Harada disease.

Authors:  Youjin Hu; Yixin Hu; Yuhua Xiao; Feng Wen; Shaochong Zhang; Dan Liang; Lishi Su; Yang Deng; Jiawen Luo; Jingsong Ou; Mingzhi Lu; Yanhua Hong; Wei Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-28       Impact factor: 11.205

Review 3.  Mesenchymal stromal cells for the treatment of ocular autoimmune diseases.

Authors:  Joo Youn Oh; Ryang Hwa Lee
Journal:  Prog Retin Eye Res       Date:  2021-03-26       Impact factor: 21.198

4.  Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis.

Authors:  Sabina Kaczanowska; Daniel W Beury; Vishaka Gopalan; Arielle K Tycko; Haiying Qin; Miranda E Clements; Justin Drake; Chiadika Nwanze; Meera Murgai; Zachary Rae; Wei Ju; Katherine A Alexander; Jessica Kline; Cristina F Contreras; Kristin M Wessel; Shil Patel; Sridhar Hannenhalli; Michael C Kelly; Rosandra N Kaplan
Journal:  Cell       Date:  2021-03-24       Impact factor: 66.850

5.  Small-molecule antagonist of VLA-4 (GW559090) attenuated neuro-inflammation by targeting Th17 cell trafficking across the blood-retinal barrier in experimental autoimmune uveitis.

Authors:  Yi Hsing Chen; Malihe Eskandarpour; Xiaozhe Zhang; Grazyna Galatowicz; John Greenwood; Sue Lightman; Virginia Calder
Journal:  J Neuroinflammation       Date:  2021-02-18       Impact factor: 8.322

6.  Effect of small extracellular vesicles derived from IL-10-overexpressing mesenchymal stem cells on experimental autoimmune uveitis.

Authors:  Yongtao Li; Xinjun Ren; Zhihui Zhang; Yanan Duan; Huan Li; Shuang Chen; Hui Shao; Xiaorong Li; Xiaomin Zhang
Journal:  Stem Cell Res Ther       Date:  2022-03-07       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.